Thrombopoietin receptor agonist (TPO-RA)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Thrombopoietin receptor agonist (TPO-RA), covering 2024-06-27 to 2024-06-27. Get the full timeline:
Most recent: Clinical Trial Update: TPO-RA Treatment on Immune Tolerance Induction of ITP Patients With Sustained Platelet Recovery After Treatment Termination [Phase 2]